Literature DB >> 9033975

Tularemia.

R F Jacobs1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9033975

Source DB:  PubMed          Journal:  Adv Pediatr Infect Dis        ISSN: 0884-9404


× No keyword cloud information.
  5 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Bactericidal activities of antibiotics against intracellular Francisella tularensis.

Authors:  M Maurin; N F Mersali; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.

Authors:  Gary R Klimpel; Tonyia Eaves-Pyles; Scott T Moen; Joanna Taormina; Johnny W Peterson; Ashok K Chopra; David W Niesel; Paige Carness; Judith L Haithcoat; Michelle Kirtley; Abdelhakim Ben Nasr
Journal:  Vaccine       Date:  2008-10-16       Impact factor: 3.641

4.  Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensis.

Authors:  Tonyia Eaves-Pyles; Jignesh Patel; Emma Arigi; Yingzi Cong; Anthony Cao; Nisha Garg; Monisha Dhiman; Richard B Pyles; Bernard Arulanandam; Aaron L Miller; Vsevolod L Popov; Lynn Soong; Eric D Carlsen; Ciro Coletta; Csaba Szabo; Igor C Almeida
Journal:  Mol Med       Date:  2013-08-28       Impact factor: 6.354

5.  Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.

Authors:  Megan Gentry; Joanna Taormina; Richard B Pyles; Linsey Yeager; Michelle Kirtley; Vsevolod L Popov; Gary Klimpel; Tonyia Eaves-Pyles
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.